Sanofi's Lantus avoids meltdown after cancer scare | Reuters
Links shared publicly online about this topic.
- 1,865total visits
Sanofi's Lantus avoids meltdown after cancer scare | Reuters
* Prescriptions for diabetes treatment holding up * Analysts review worst-case forecasts for Lantus sales * Sanofi expected to reiterate confidence at H1 results * Shares up 2.6 percent By
View full resource at reuters.com
Tags: Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Cancer, Drug, Lantus, Sanofi-Aventis
Most Recently Shared on July 28, 2009 at 2:26 pm By:
Sales of Lantus, long-acting insulin, hold up, despite studies possibly linking it to cancer RT @reutersBenHir http://is.gd/1R8Yc
Sanofi's Lantus avoids meltdown after cancer scare | Reuters
reuters.com — “* Prescriptions for diabetes treatment holding up * Analysts review worst-case forecasts for Lantus sales * Sanofi expected to reiterate confidence at H1 results * Shares up 2.6 percent By” View full resource at reuters.com
Most Recently Shared on July 28, 2009 at 2:19 pm By:
Ben Hirschler Health Communicator
Sanofi's Lantus avoids sales meltdown for now at least. But expect story to come back at EASD meeting in Sept http://tinyurl.com/m8xj9b
Advertisement
